Indefinite Delivery Contract 36C24925D0025

Award Date 10/1/24
Last Date to Order 9/30/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $415,022.25 contract has a period of performance from September 1, 2024 to August 31, 2027 and is for the provision of Roche Diagnostics' COVID-19 reagents and Cobas supplies to the VA. Roche Diagnostics has been awarded numerous...
This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at a ceiling of $389,666.38, provides the VA with a 5-year ordering period to acquire Roche's clinical chemistry analyzers, reagents, and testing services to support immunochemistry, hematology, molecular diagnostics,...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 17, to Roche Diagnostics Corporation for the provision of Roche Ventana reagents and consumables. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment and supplies to various federal agencies, including the VA, Department of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Roche Diagnostics Corporation an indefinite delivery contract for reagents. The IDV has a potential value of $700,000 and a period of performance through September 1, 2027. No set-aside was used. Under the IDV, Roche Diagnostics has received multiple delivery orders for reagents to support medical testing programs across VISN 1 facilities. Delivery orders ranged in value from...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Network Contracting Office 9 to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $470,851.70, is for the delivery of Roche HE600 reagents over a period ending on September 30, 2029. This delivery order is part of a larger IDC held by Roche to supply chemistry reagents to VA and military treatment facilities across a...
The federal contract IDV award was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The $733,089.60 single-award IDC has an ultimate completion date of July 31, 2024 and does not utilize any set-aside designations. Under this IDC, Roche Diagnostics has been awarded multiple firm fixed price...
The key information from the federal contract IDV award and associated task orders is as follows: The U.S. Department of Veterans Affairs (VA) awarded a $700 million Indefinite Delivery Vehicle (IDV) contract to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The IDV, a Federal Supply Schedule contract, provides Roche the ability to deliver critical care analyzers, reagents, test kits, and associated...
The key points are: This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) to Roche Diagnostics Corporation, a large business manufacturer and distributor of in-vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $991,073.55 IDC has a period of performance through September 30, 2024 and provides a vehicle for VISN 9 to acquire reagents, test kits, test sets, and...
The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 23 (VISN 23), awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp., for the delivery of microbiology reagents to the Minneapolis VA Medical Center. The contract, valued at up to $1,989,999.99, has a period of performance through September 30, 2029. Under this IDC, the VA issued a $380,057.46 firm-fixed-price delivery order to Roche...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
  • 36C24925D0025
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This federal contract IDV award by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides for the delivery of reagents over a period of 3 years from October 1, 2024 to September 30, 2027. The contract, valued at $225,409.54, is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation.

Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The company has a history of providing critical care analyzers, reagents, test kits, and other laboratory equipment and supplies to various federal agencies, including the Department of Veterans Affairs, Department of Defense, Department of Health and Human Services, and others, often through General Services Administration (GSA) Schedule contracts. This IDV award allows the VA to acquire the necessary reagents to support its laboratory testing capabilities across its healthcare facilities.

Generated 10/16/24, 9:06 AM